MedTrace Logo

Return to Physical Activity Following Injury: Towards Understanding a More Accessible Solution for Shorter Recovery Time.

NCT03899714 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-04-02

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of cryotherapy application on hip adductors and ankle evertors on the Overall Stability Index (OSI), the Medio-Lateral Stability Index (MLSI), and the Antero-Posterior Stability Index (APSI) in healthy adult females.

Conditions

  • Cryotherapy

Interventions

OTHER

Cryotherapy

Crushed ice in a plastic bag will be used, as it is a widely accessible and financially convenient method of cryotherapy. One half of a kilogram of ice will be placed in a plastic bag. The plastic bags will be 17 cm wide and 22 cm long. The air will be squeezed out of the bag and it will be sealed. The bag will be wrapped in a wet towel and applied to the tested area. Every five bags of crushed ice will be kept in an insulated foam container containing one kilogram of dry ice. Dry ice has a temperature of negative 80 degrees Celsius, and is used to keep the bags of crushed ice in a frozen state till the participants are briefed and the testing began.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ayman G Matar, PhD · Lecturer of Biomechanics

  • Nagui S Nassif, Prof. · Assistant Professor of Biomechanics

  • Naglaa M Elhafez, Prof. · Professor of Biomechanics

  • Ghada M Elhafez, Prof. · Professor of Biomechanics

  • Sondus Hassounah, Public Health Teaching Fellow · Public Health Teaching Fellow

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2019-05-15
Completion
2019-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03899714 on ClinicalTrials.gov